Betting on Tech
Health Care: Drugs
POZEN Inc. (POZN: NASDAQ)
$5.03 -0.04 | -0.79%
06/17/13 - 04:00 PM ET
Portfolios with POZN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- UserSm. Magic July 5 13
- ContributorStocks Under-$10 Moving Hig...
- Userwright stocks
- Contributor10 Biotech Stocks Facing FD...
- UserHouxie's stuff
- UserSnoops Millionaire Picks
- UserMMD-05-05-08_END DAY
- Usergrtdane Portfolio 1
Latest POZN Headlines from TheStreet
- 5 Stocks Under $10 Set to Soar 04.18.13 | 02:04 pm
- POZEN Inc. Stock Downgraded (POZN) 04.03.13 | 05:04 am
- 5 Stocks Under $10 Set to Soar Higher 09.27.12 | 01:09 pm
- POZEN's CEO Presents At Update Conference (Transcript) 08.24.12 | 03:08 pm
- POZEN's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.01.12 | 04:08 pm
- POZEN Stock Gaps Down On Today's Open (POZN) 06.21.12 | 09:06 am
- POZEN Stock Gaps Down On Today's Open (POZN) 04.27.12 | 11:04 am
- POZEN Stock Hits New 52-Week High (POZN) 04.26.12 | 09:04 am
- POZEN Reaches New 52-Week High (POZN) 04.17.12 | 10:04 am
- 8 Stocks Under $10 Making Big Moves 03.22.12 | 12:03 pm
Press Releases for POZN
- POZEN Submits New Drug Application For PA32540/PA8140 - Business Wire 03.27.13 | 07:03 am
- POZEN To Present At The 25th Annual ROTH Conference - Business Wire 03.07.13 | 07:03 am
- POZEN Reports Fourth Quarter & Year End 2012 Results - Business Wire 03.06.13 | 07:03 am
- POZEN Announces March 6th Webcast Of Fourth Quarter And Year End 2012 Results - Business Wire 02.27.13 | 07:02 am
- POZEN Presents Positive PA32540 Phase 3 Data At The 2013 International Stroke Conference - Business Wire 02.08.13 | 07:02 am
- POZEN To Present At The 24th Annual Piper Jaffray Healthcare Conference - Business Wire 11.19.12 | 07:11 am
- POZEN Announces Positive Results For The PA8140-102 Bioavailability Study - Business Wire 11.15.12 | 04:11 pm
- POZEN Reports Third Quarter 2012 Financial Results And Positive PA32540 Clinical Updates - Business Wire 11.08.12 | 07:11 am
- POZEN Presents Positive PA32540 Pivotal Phase 3 Data At The American Heart Association Scientific Sessions 2012 - Business Wire 11.06.12 | 06:11 pm
- POZEN Announces November 8th Webcast Of Third Quarter 2012 Results And November 6th Presentation Of Phase 3 Results For PA32540 At AHA’s Scientific Sessions 2012 - Business Wire 10.29.12 | 02:10 pm
Partner Headlines for POZN
- Understanding The Market Opportunity For Pozen's Safer Aspirin - Seeking Alpha 01.16.13 | 09:01 am
- Morning Market Losers - Benzinga 06.21.12 | 09:06 am
- Pozen Has No Debt And Plenty Of Resources For 2012 NDA Filing - Seeking Alpha 11.29.11 | 09:11 am
- MICROCAP MOVERS FOR FRIDAY NOVEMBER 25, 2011 - Benzinga 11.25.11 | 04:11 pm
- UPDATE: Brean Murray Maintains Buy, Lowers PT to $7 on Pozen - Benzinga 11.25.11 | 09:11 am
- Financial Breakfast: Morning News Summary for November 25, 2011 - Benzinga 11.25.11 | 09:11 am
- IPO Preview: Horizon Pharma - Seeking Alpha 07.25.11 | 09:07 am
- Pozen Continues Fighting Off Dr. Reddy's Labs - Seeking Alpha 04.26.11 | 09:04 am
- Pozen's Success Will Depend on Execution of Unique Marketing Strategies - Seeking Alpha 03.13.11 | 09:03 am
- Pfizer's Osteoarthritis Drug Runs Into Unique Roadblock - Seeking Alpha 10.04.10 | 08:10 am
